With over 15 years of experience, Barnett has built a career combining business, technical and sales acumen, most recently as Vice President of Strategic Alliances and Service Integrators for Qualys, where he revamped the go-to-market strategy for partners and service providers. He said:

“I know that security posture validation platforms can materially change the way security practitioners defend their organizations more than any other piece of technology or new methodology. Cymulate’s platform is already delivering crucial value and has huge growth potential. Moreover, the leadership team has cultivated an inclusive, diverse and welcoming company culture with a team of exceptionally talented individuals that I’m excited to join.”

Previously, he was Senior Manager within Deloitte’s Cyber Risk Services Practice, leading IT Risk and Security management consulting services for Fortune 500 clients and building their security posture solutions. Other prior roles include VP of Business Development at a cybersecurity firm and Senior Director of Portfolio Programs at Optiv where he served as a technical advisor for M&A activities.

“We are honored to thank our clients and our inspiring team for this award. It is with gratitude and fulfilled purpose that we have the opportunity to work with the world’s leading oncologists and biopharma companies making a difference to patients with cancer.”

The top 500 companies are being featured in the September issue of Inc., available on newsstands now. The list represents a look at successful companies within the American economy’s most dynamic segment – its independent small businesses. The 2020 Inc. 5000 companies have been highly competitive in their own markets. Zack Lentz, President and Chief Strategy Officer, commented:

“Growth for us means innovation and creating opportunities for our team. Our growth reflects the investments we have made in finding and hiring the best people across the globe.”

Vaniam Group continues to grow in 2021 with the expansion of the company’s medical communications offering in Europe and internationally to healthcare organizations focused on advancing the science in oncology and hematology. This substantial client growth builds on Vaniam Group’s collective strength in strategic client partnership and collaborative integration with US-based teams.